{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:48:41Z","timestamp":1777636121160,"version":"3.51.4"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/wnf.0b013e3181c47569","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T06:52:14Z","timestamp":1267080734000},"page":"17-21","source":"Crossref","is-referenced-by-count":112,"title":["Safety, Tolerability, and Cerebrospinal Fluid Penetration of Ursodeoxycholic Acid in Patients With Amyotrophic Lateral Sclerosis"],"prefix":"10.1097","volume":"33","author":[{"given":"Gareth J.","family":"Parry","sequence":"first","affiliation":[]},{"given":"Cecilia M.P.","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Marcia M.","family":"Aranha","sequence":"additional","affiliation":[]},{"given":"Sarah J.","family":"Hilbert","sequence":"additional","affiliation":[]},{"given":"Cynthia","family":"Davey","sequence":"additional","affiliation":[]},{"given":"Praful","family":"Kelkar","sequence":"additional","affiliation":[]},{"given":"Walter C.","family":"Low","sequence":"additional","affiliation":[]},{"given":"Clifford J.","family":"Steer","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-5-20210203","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis.","volume":"344","author":"Rowland","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-5-20210203","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X","article-title":"Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis.","volume":"49","author":"Almer","year":"2001","journal-title":"Ann Neurol"},{"key":"R3-5-20210203","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0306-4522(00)00173-1","article-title":"Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury.","volume":"99","author":"Li","year":"2000","journal-title":"Neuroscience"},{"key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00005072-199905000-00005","article-title":"Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism.","volume":"58","author":"Martin","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"issue":"suppl","key":"R5-5-20210203","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0022-510X(96)00073-1","article-title":"Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis.","volume":"139","author":"Schiffer","year":"1996","journal-title":"J Neurol Sci"},{"key":"R6-5-20210203","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis.","volume":"3","author":"Beuers","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"R7-5-20210203","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/hep.510290220","article-title":"Differences in the metabolism and disposition of ursodeoxycholic acid and its taurine-conjugated species in patients with primary biliary cirrhosis.","volume":"29","author":"Invernizzi","year":"1999","journal-title":"Hepatology"},{"key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.1073\/pnas.162362299","article-title":"Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease.","volume":"99","author":"Keene","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-5-20210203","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1073\/pnas.1031632100","article-title":"Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats.","volume":"100","author":"Rodrigues","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-5-20210203","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00004647-200204000-00010","article-title":"Neuroprotection by a bile acid in an acute stroke model in the rat.","volume":"22","author":"Rodrigues","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"R11-5-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3727\/096020198389960","article-title":"Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease.","volume":"11","author":"Duan","year":"2002","journal-title":"Cell Transplant"},{"key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"42655","DOI":"10.1074\/jbc.M505910200","article-title":"Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans.","volume":"280","author":"Ved","year":"2005","journal-title":"J Biol Chem"},{"key":"R13-5-20210203","first-page":"1706","article-title":"Tool from ancient pharmacopoeia prevents vision loss.","volume":"12","author":"Boatright","year":"2006","journal-title":"Mol Vis"},{"key":"R14-5-20210203","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbadis.2008.05.005","article-title":"Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of familial amyloidotic polyneuropathy.","volume":"1782","author":"Macedo","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"R15-5-20210203","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jocn.2007.06.002","article-title":"Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats.","volume":"15","author":"Colak","year":"2008","journal-title":"J Clin Neurosci"},{"key":"R16-5-20210203","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"Revised criteria for the diagnosis of amyotrophic lateral sclerosis.","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"R17-5-20210203","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0009-8981(82)90190-5","article-title":"A rapid method for the quantitative extraction of bile acids and their conjugates from serum using commercially available reverse-phase octadecylsilane bonded silica cartridges.","volume":"125","author":"Setchell","year":"1982","journal-title":"Clin Chim Acta"},{"key":"R18-5-20210203","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00003495-198427020-00001","article-title":"Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.","volume":"27","author":"Ward","year":"1984","journal-title":"Drugs"},{"key":"R19-5-20210203","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00003088-199630050-00002","article-title":"Clinical pharmacokinetics of therapeutic bile acids.","volume":"30","author":"Crosignani","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"R20-5-20210203","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2119\/2003-00042.Rodrigues","article-title":"Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway.","volume":"9","author":"Sola","year":"2003","journal-title":"Mol Med"},{"key":"R21-5-20210203","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2990.2007.00850.x","article-title":"Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis.","volume":"33","author":"Dewil","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R22-5-20210203","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2007.02.088","article-title":"Transcription factor p53 in degenerating spinal cords.","volume":"1150","author":"Eve","year":"2007","journal-title":"Brain Res"},{"key":"R23-5-20210203","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.","volume":"6","author":"Gordon","year":"2007","journal-title":"Lancet Neurol"},{"key":"R24-5-20210203","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1212\/01.wnl.0000269676.07319.09","article-title":"Phase II\/III randomized trial of TCH346 in patients with ALS.","volume":"69","author":"Miller","year":"2007","journal-title":"Neurology"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002826-201001000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:52:02Z","timestamp":1618278722000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201001000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181c47569","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}